Form 4 for PHIO Phio Pharmaceuticals Corp.
Accepted 2022-11-29 00:00:00 ET · period of report 2022-11-25 · accession 0001209191-22-058942 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2022-11-29 | 2022-11-25+ | PHIO | Bitterman Robert J | Interim Executive COB, Dir | P - Purchase | $0.4184 | +2,715 | 68.3K | +4% | +$1,136 |
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common stock, $0.0001 par value | 2022-11-29 | P | A | 215 | $0.4 | 68,541 | D | — | — | (F1) Includes shares of common stock underlying unvested restricted stock units. |
| 2 | Common | Common stock, $0.0001 par value | 2022-11-25 | P | A | 2,500 | $0.42 | 68,326 | D | — | — | (F1) Includes shares of common stock underlying unvested restricted stock units. |